or
Remember me
Back
“Q3 adds to KBL’s growing record of consistent execution since emerging from the pandemic, and reflects the favourable industry fundamentals (high surgical backlog and healthy leisure and business travel demand),” he said. “The shares are trading only at 7.6 times forward consensus EBITDA (versus five-year average of 9.1 times), which we do not think fairly represents the stock’s attractive risk/reward trade-off.”
A daily snapshot of everything from market open to close.